Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients

R. Tedeschi, J. Dillner, P. De Paoli

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The Epstein-Barr virus BZLF1-encoded replication activator (ZEBRA) is a key mediate of reactivation from latency to the viral productive cycle. In the present study, the serum antibody responses against three defined ZEBRA epitopes (designated ZEBRA-1, -19, and -22) were determined for 50 human immunodeficiency virus (HIV)-seropositive patients and 100 matched healthy control subjects. The anti-ZEBRA responses were more commonly found among HIV-seropositive patients than among healthy controls for all the three ZEBRA epitopes tested (P <0.0003, P <0.003, and P <0.001, respectively). Comparison of ZEBRA antibody levels with the degree of immunodeficiency (CD4 cell counts), CDC grouping, and HIV p24 antigen positivity showed little association, suggesting that induction of ZEBRA antibodies is an early event after HIV infection.

Original languageEnglish
Pages (from-to)363-364
Number of pages2
JournalClinical and Diagnostic Laboratory Immunology
Volume3
Issue number3
Publication statusPublished - 1996

Fingerprint

Human Immunodeficiency Virus Proteins
Trans-Activators
Human Herpesvirus 4
Viruses
Antibody Formation
Epitopes
HIV
Antibodies
Virus Latency
Virus Diseases
Centers for Disease Control and Prevention (U.S.)
CD4 Lymphocyte Count
Healthy Volunteers
Antigens
Serum

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Clinical Biochemistry
  • Immunology

Cite this

@article{a82c8b035e494d449118f7b7f8386a8e,
title = "Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients",
abstract = "The Epstein-Barr virus BZLF1-encoded replication activator (ZEBRA) is a key mediate of reactivation from latency to the viral productive cycle. In the present study, the serum antibody responses against three defined ZEBRA epitopes (designated ZEBRA-1, -19, and -22) were determined for 50 human immunodeficiency virus (HIV)-seropositive patients and 100 matched healthy control subjects. The anti-ZEBRA responses were more commonly found among HIV-seropositive patients than among healthy controls for all the three ZEBRA epitopes tested (P <0.0003, P <0.003, and P <0.001, respectively). Comparison of ZEBRA antibody levels with the degree of immunodeficiency (CD4 cell counts), CDC grouping, and HIV p24 antigen positivity showed little association, suggesting that induction of ZEBRA antibodies is an early event after HIV infection.",
author = "R. Tedeschi and J. Dillner and {De Paoli}, P.",
year = "1996",
language = "English",
volume = "3",
pages = "363--364",
journal = "Clinical and Diagnostic Laboratory Immunology",
issn = "1071-412X",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients

AU - Tedeschi, R.

AU - Dillner, J.

AU - De Paoli, P.

PY - 1996

Y1 - 1996

N2 - The Epstein-Barr virus BZLF1-encoded replication activator (ZEBRA) is a key mediate of reactivation from latency to the viral productive cycle. In the present study, the serum antibody responses against three defined ZEBRA epitopes (designated ZEBRA-1, -19, and -22) were determined for 50 human immunodeficiency virus (HIV)-seropositive patients and 100 matched healthy control subjects. The anti-ZEBRA responses were more commonly found among HIV-seropositive patients than among healthy controls for all the three ZEBRA epitopes tested (P <0.0003, P <0.003, and P <0.001, respectively). Comparison of ZEBRA antibody levels with the degree of immunodeficiency (CD4 cell counts), CDC grouping, and HIV p24 antigen positivity showed little association, suggesting that induction of ZEBRA antibodies is an early event after HIV infection.

AB - The Epstein-Barr virus BZLF1-encoded replication activator (ZEBRA) is a key mediate of reactivation from latency to the viral productive cycle. In the present study, the serum antibody responses against three defined ZEBRA epitopes (designated ZEBRA-1, -19, and -22) were determined for 50 human immunodeficiency virus (HIV)-seropositive patients and 100 matched healthy control subjects. The anti-ZEBRA responses were more commonly found among HIV-seropositive patients than among healthy controls for all the three ZEBRA epitopes tested (P <0.0003, P <0.003, and P <0.001, respectively). Comparison of ZEBRA antibody levels with the degree of immunodeficiency (CD4 cell counts), CDC grouping, and HIV p24 antigen positivity showed little association, suggesting that induction of ZEBRA antibodies is an early event after HIV infection.

UR - http://www.scopus.com/inward/record.url?scp=0030014634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030014634&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 363

EP - 364

JO - Clinical and Diagnostic Laboratory Immunology

JF - Clinical and Diagnostic Laboratory Immunology

SN - 1071-412X

IS - 3

ER -